| Depressed Affect (Nagel 2018) |
2.26 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Neuroticism (Nagel 2018) |
2.45 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Worry (Nagel 2018) |
1.45 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Crohns Disease (2017) |
5.34 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 |
| Irritable Bowel Disease (IBD) |
5.15 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 EIF2S2P3 |
| Ulcerative Colitis (UC) |
2.45 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Verbal and Numeric Reasoning (VNR) |
2.58 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Breast Cancer |
7.09 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Body Mass Index (BMI) (2010) |
2.83 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Crohns Disease (2012) |
2.68 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Fasting Glucose |
6.63 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 TCF7L2 |
| HbA1C |
4.16 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Triglycerides |
1.88 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Type 2 Diabetes (T2D) (2012) |
30.40 |
4 |
3 |
6.7 |
0.40 |
0.59810 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Ulcerative Colitis |
2.93 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Blood Eosinophil Count |
4.03 |
2 |
2 |
4.4 |
0.00 |
1.00000 |
AC010883.5 EIF2S2P3 |
| Blood Platelet Count |
8.32 |
4 |
2 |
4.4 |
-0.27 |
0.73399 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Blood Red Count |
1.20 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 IGF2BP2 |
| Blood White Count |
0.39 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Heel T-Score |
4.09 |
3 |
2 |
4.4 |
0.00 |
1.00000 |
AC010883.5 IGF2BP2 TCF7L2 |
| BMI |
1.92 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Height |
0.61 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Waist Hip Ratio (WHR) |
9.37 |
4 |
3 |
6.7 |
0.79 |
0.21259 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Systolic Blood Pressure |
1.66 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Allergy or Eczema |
2.37 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Cardiovascular Disease |
1.28 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Hypothyroidism (self reported) |
3.70 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 IGF2BP2 |
| Respiratory disease |
2.83 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Type 2 Diabetes (T2D) (2018) |
73.53 |
4 |
4 |
8.9 |
0.98 |
0.01785 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Lung FEV1/FVC ratio |
4.27 |
2 |
2 |
4.4 |
0.00 |
1.00000 |
AC010883.5 IGF2BP2 |
| Lung FVC |
1.37 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Neuroticism |
1.69 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Chronotype (morning person) |
1.55 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Hair Pigment |
0.24 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Hand grip strength (left) |
1.75 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Number of treatments/medications taken |
2.42 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Ever had hysterectomy (womb removed) |
3.46 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Eye problems/disorders: Diabetes related eye disease |
12.94 |
3 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 IGF2BP2 TCF7L2 |
| Vitamin and mineral supplements |
2.08 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Medication: Metformin |
46.63 |
4 |
4 |
8.9 |
0.99 |
0.01179 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Diabetes (mother) |
33.83 |
4 |
3 |
6.7 |
0.99 |
0.00509 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Impedance of leg (right) |
2.57 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Leg fat-free mass (left) |
0.68 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Trunk fat percentage |
1.48 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Hand grip strength (right) |
2.07 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Maternal smoking around birth |
2.06 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Fed-up feelings |
3.44 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Age when periods started (menarche) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Heel bone mineral density (BMD) T-score, automated (left) |
2.96 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| High blood pressure |
1.30 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Hayfever, allergic rhinitis or eczema |
2.36 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Multivitamins +/- minerals |
1.54 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Body mass index (BMI) |
2.04 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Impedance of leg (left) |
2.88 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 |
| Leg predicted mass (left) |
0.70 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Trunk fat mass |
1.46 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Waist circumference |
1.63 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Alcohol usually taken with meals |
1.33 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Forced vital capacity (FVC) |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Heel bone mineral density (BMD) T-score, automated (right) |
2.57 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Heart attack |
3.88 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Allergy |
2.24 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Diabetes (self-reported) |
53.21 |
4 |
3 |
6.7 |
0.98 |
0.01769 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Medication: Simvastatin |
4.58 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 TCF7L2 |
| Illnesses of siblings |
3.80 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Neuroticism score |
2.88 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Weight |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Impedance of arm (right) |
1.66 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Arm fat percentage (right) |
1.50 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Hip circumference |
3.83 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Worrier / anxious feelings |
3.26 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Forced expiratory volume in 1-second (FEV1) |
2.29 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Asthma |
3.47 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 EIF2S2P3 |
| Medication: Cholesterol lowering |
6.69 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 TCF7L2 |
| Illnesses of mother |
4.66 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Forced expiratory volume in 1-second (FEV1), Best measure |
2.05 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Impedance of arm (left) |
2.01 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Arm fat mass (right) |
1.64 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Standing height |
0.44 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Hair/balding pattern: Pattern 4 |
2.69 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Birth weight of first child |
3.53 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Peak expiratory flow (PEF) |
5.89 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 IGF2BP2 |
| Medication: Paracetamol |
1.98 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Medication for cholesterol, blood pressure or diabetes |
4.16 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 TCF7L2 |
| Hypothyroidism/myxoedema (self-reported) |
3.13 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 IGF2BP2 |
| Birth weight |
7.59 |
3 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 EIF2S2P3 TCF7L2 |
| High blood pressure (siblings) |
2.44 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Body fat percentage |
2.06 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Leg fat percentage (right) |
2.78 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Arm fat-free mass (right) |
0.53 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Wheeze or whistling in the chest in last year |
2.74 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Age at first live birth |
1.59 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Medication for pain relief, constipation, heartburn |
2.75 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Neck or shoulder pain in last month |
1.87 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Reproduciblity of spirometry measurement using ERS/ATS criteria |
4.28 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Whole body fat mass |
1.87 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Leg fat mass (right) |
2.36 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Arm predicted mass (right) |
0.49 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Pulse rate, automated reading |
2.74 |
3 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 EIF2S2P3 TCF7L2 |
| Comparative height size at age 10 |
2.21 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 EIF2S2P3 |
| Overall health rating |
1.68 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Age at last live birth |
3.17 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Medication: Aspirin |
5.06 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Hypertension (Self-reported) |
1.28 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Illnesses of father: Heart disease |
1.83 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Illnesses of siblings: Diabetes |
22.66 |
4 |
2 |
4.4 |
0.96 |
0.04118 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Whole body fat-free mass |
0.50 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Leg fat-free mass (right) |
0.62 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Arm fat percentage (left) |
1.68 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Mood swings |
2.73 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Long-standing illness, disability or infirmity |
4.04 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Diabetes diagnosed by doctor |
62.29 |
4 |
4 |
8.9 |
1.00 |
0.00079 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Ever had stillbirth, spontaneous miscarriage or termination |
2.67 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Qualifications: nursing, teaching |
2.51 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Breast cancer (self-reported) |
2.76 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Asthma (self-reported) |
3.19 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 |
| Medication: Aspirin |
5.73 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 TCF7L2 |
| Medication: Gliclazide |
26.79 |
4 |
2 |
4.4 |
0.96 |
0.04105 |
AC010883.5 EIF2S2P3 IGF2BP2 TCF7L2 |
| Illnesses of father: None of the above (group 1) |
4.16 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
EIF2S2P3 TCF7L2 |
| Forced expiratory volume in 1-second (FEV1), predicted percentage |
2.60 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Whole body water mass |
0.49 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Leg predicted mass (right) |
0.65 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Arm fat mass (left) |
1.61 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Number of self-reported non-cancer illnesses |
2.32 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Average weekly champagne plus white wine intake |
3.23 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| High cholesterol (Self-reported) |
2.44 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Medication: Paracetamol |
1.57 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Medication: Atorvastatin |
6.57 |
2 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 TCF7L2 |
| Basal metabolic rate |
0.64 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Leg fat percentage (left) |
2.99 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Arm fat-free mass (left) |
0.64 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Irritability |
3.12 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Diastolic blood pressure, automated reading |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Myopia |
1.88 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Vascular/heart problems diagnosed by doctor |
1.66 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Cholesterol lowering medication |
5.81 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |
| Heart attack/myocardial infarction (self-reported) |
3.96 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
AC010883.5 |
| Heart disease (siblings) |
1.88 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
IGF2BP2 |
| Impedance of whole body |
2.51 |
2 |
1 |
2.2 |
0.00 |
1.00000 |
AC010883.5 TCF7L2 |
| Leg fat mass (left) |
2.48 |
1 |
1 |
2.2 |
0.00 |
1.00000 |
TCF7L2 |
| Arm predicted mass (left) |
0.60 |
1 |
0 |
0.0 |
0.00 |
1.00000 |
TCF7L2 |